25
Community Validation of Influenza-like Illness as a Predictor of Influenza Jonathan L. Temte, MD/PhD & Alexis Eastman, MS-2 University of Wisconsin School of Medicine and Public Health Peter A. Shult, PhD, Carol J. Kirk & Mary Wedig Wisconsin State Laboratory of Hygiene Madison, Wisconsin

Community Validation of Influenza-like Illness as a Predictor of Influenza Jonathan L. Temte, MD/PhD & Alexis Eastman, MS-2 University of Wisconsin School

Embed Size (px)

Citation preview

Page 1: Community Validation of Influenza-like Illness as a Predictor of Influenza Jonathan L. Temte, MD/PhD & Alexis Eastman, MS-2 University of Wisconsin School

Community Validation of

Influenza-like Illness as a Predictor of

InfluenzaJonathan L. Temte, MD/PhD & Alexis Eastman, MS-2

University of Wisconsin School of Medicine and Public Health

Peter A. Shult, PhD, Carol J. Kirk & Mary Wedig

Wisconsin State Laboratory of Hygiene

Madison, Wisconsin

Page 2: Community Validation of Influenza-like Illness as a Predictor of Influenza Jonathan L. Temte, MD/PhD & Alexis Eastman, MS-2 University of Wisconsin School

Influenza-like Illness

Definition Fever of 100oF (37.8oC) or higher Cough and/or Sore Throat Not due to any other illness

Utility Simple and elegant Clinically relevant Easily ascertained

Page 3: Community Validation of Influenza-like Illness as a Predictor of Influenza Jonathan L. Temte, MD/PhD & Alexis Eastman, MS-2 University of Wisconsin School

ILI uses

Clinical identification of influenza infection High PPV from research protocols

Adults Children

Age 65+

Age 25-64

Age 5-24

Age 0-4

ILI in WisconsinOct. 2007 thtough Sept. 2008

Community surveillance of influenza

Page 4: Community Validation of Influenza-like Illness as a Predictor of Influenza Jonathan L. Temte, MD/PhD & Alexis Eastman, MS-2 University of Wisconsin School

Factors Affecting Symptoms

AgeAge

ImmuneImmuneStatusStatus

UnderlyingUnderlyingDiseaseDisease

Viral StrainViral Strain

Viral SubtypeViral Subtype

Host Factors Viral Factors

Page 5: Community Validation of Influenza-like Illness as a Predictor of Influenza Jonathan L. Temte, MD/PhD & Alexis Eastman, MS-2 University of Wisconsin School

Purpose of Study

Review the contents of a large database Surveillance data emerging from a

partnership between a public health laboratory and primary care clinicians

Symptoms and virus identification

Validate ILI for influenza infection Community—not research—perspective

Page 6: Community Validation of Influenza-like Illness as a Predictor of Influenza Jonathan L. Temte, MD/PhD & Alexis Eastman, MS-2 University of Wisconsin School

The Surveillance Database

Partnership of WSLH and UW-DFM since 1994 Major modification of symptom check off in 1997

Opportunistic sampling with “fee-exempt” virus culture physicians obtain specimens, record demographic and symptom

data, sample is transported to WSLH by courier. Standard culture methods with isolation rate = 45% Limited, de-identified data used

1997-2007 IRB approved

3,796 episodes of acute respiratory illness care available

Page 7: Community Validation of Influenza-like Illness as a Predictor of Influenza Jonathan L. Temte, MD/PhD & Alexis Eastman, MS-2 University of Wisconsin School

Preferential Collection from

Children and Young Adults

0

50

100

150

200

250

300

350

0 5 10

15

20

25

30

35

40

45

50

55

60

65

70

75

80

85

90

95

100

Age of Patient

No

. o

f S

pecim

en

s Range: 0 – 103 years

55.6% female

Page 8: Community Validation of Influenza-like Illness as a Predictor of Influenza Jonathan L. Temte, MD/PhD & Alexis Eastman, MS-2 University of Wisconsin School

PredictorsWorking definition of ILI

F+CorST F = Fever on symptom checklist

No requirement for level or documentation

CorST = Cough and/or Sore Throat

sF+CorST (includes seasonality) December through March Period with > 90% of influenza cases

Page 9: Community Validation of Influenza-like Illness as a Predictor of Influenza Jonathan L. Temte, MD/PhD & Alexis Eastman, MS-2 University of Wisconsin School

Outcomesinfluenza isolation

Paradigm 1: “clinical primary care” Influenza (+) vs. all other specimens

Influenza = 1230 Non-influenza + no virus isolated = 2566

Paradigm 2: “ideal virus capture” Influenza (+) vs. non-influenza virus (+)

Influenza = 1230 Non-influenza = 523

Page 10: Community Validation of Influenza-like Illness as a Predictor of Influenza Jonathan L. Temte, MD/PhD & Alexis Eastman, MS-2 University of Wisconsin School

Distribution of outcomes

Reference

population

Season

included

Criteria

used

Influenza (+)

Influenza (-)

All ARI specimens

Yes

sF+CorST (+)

1020 1034

sF+CorST (-)

210 1532

No

sF+CorST (+)

1082 1529

sF+CorST (-)

148 1037

Page 11: Community Validation of Influenza-like Illness as a Predictor of Influenza Jonathan L. Temte, MD/PhD & Alexis Eastman, MS-2 University of Wisconsin School

Reference

population

Season

included

Criteria

used

Influenza (+)

Influenza (-)

Virus (+) specimens

Yes

sF+CorST (+)

1020 188

sF+CorST (-)

210 335

No

sF+CorST (+)

1082 302

sF+CorST (-)

148 221

Distribution of outcomes

Page 12: Community Validation of Influenza-like Illness as a Predictor of Influenza Jonathan L. Temte, MD/PhD & Alexis Eastman, MS-2 University of Wisconsin School

Performance Characteristics

Criteria Referencepopulation

OR

flu

Sens Spec PPV NPV

F+CorST All ARI 4.96 0.88 0.40 0.41 0.88

F+CorST Virus (+) 5.25 0.88 0.42 0.78 0.60

sF+CorST All ARI 7.20 0.83 0.60 0.50 0.88

sF+CorST Virus (+) 8.66 0.83 0.64 0.84 0.62

Page 13: Community Validation of Influenza-like Illness as a Predictor of Influenza Jonathan L. Temte, MD/PhD & Alexis Eastman, MS-2 University of Wisconsin School

Additional Fiddlingassessing effects of age

Concentrate on seasonal data Clinician informed by surveillance

Concentrate on virus (+) specimens Symptomatic patient Early in illness Collection technique good

Concentrate on age categories 0-4 5-24 25-64 65+

Page 14: Community Validation of Influenza-like Illness as a Predictor of Influenza Jonathan L. Temte, MD/PhD & Alexis Eastman, MS-2 University of Wisconsin School

Effects of age(reference age = 25-64 years)Binary logistic regression via Minitab –

Release 13.1Factor Odds Ratio 95% CI

sF+CorST 7.55* 5.81 – 9.80

0-4 years 0.10* 0.07 – 0.14

5-24 years 1.21 0.90 – 1.65

25-64 years reference

65+ years 1.67 0.86 – 3.25

* P<0.001

Page 15: Community Validation of Influenza-like Illness as a Predictor of Influenza Jonathan L. Temte, MD/PhD & Alexis Eastman, MS-2 University of Wisconsin School

What about little kids?the percent of ILI cases due to:

Virus 0-4 years 5+ years

Influenza 34.8 84.7

Adenovirus 6.6 3.2

Parainfluenza 14.4 3.3

Rhinovirus 1.7 3.7

RSV 37.0 1.4

Herpes simplex 1.1 2.0

Enterovirus 2.9 0.8

Page 16: Community Validation of Influenza-like Illness as a Predictor of Influenza Jonathan L. Temte, MD/PhD & Alexis Eastman, MS-2 University of Wisconsin School

Conclusions ILI (F+CorST) performs well

Public health tool for surveillance Early detection of influenza High sensitivity ( 0.88) Limited by low specificity (0.40)

but fined tuned by virological methods

ILI (sF+CorST) performs well Clinician tool for diagnosis of influenza Informed by public health surveillance High PPV (0.84); moderate NPV Excluding young children raises PPV to 0.90

Page 17: Community Validation of Influenza-like Illness as a Predictor of Influenza Jonathan L. Temte, MD/PhD & Alexis Eastman, MS-2 University of Wisconsin School

Conclusions

Influenza is the primary cause of ILI in patients age 5+ years

Many viruses can cause ILI in children 0-4 years of age. ILI should not be used for diagnosis alone in this group.

ILI for predicting influenza infection has been validated in a primary care, community-based population

Page 18: Community Validation of Influenza-like Illness as a Predictor of Influenza Jonathan L. Temte, MD/PhD & Alexis Eastman, MS-2 University of Wisconsin School

Final WordsIf influenza is in the community and

your patient is over 4 years oldIs it influenza?

F+CorST

“Of Course”

Page 19: Community Validation of Influenza-like Illness as a Predictor of Influenza Jonathan L. Temte, MD/PhD & Alexis Eastman, MS-2 University of Wisconsin School

Acknowledgements

Wisconsin Primary Care Clinicians UW-DFM residency clinics Numerous private physicians

UW-DFM Summer Student Research and Clinical Assistantship Program Ms. Alexis Eastman

Wisconsin State Laboratory of Hygiene

Page 20: Community Validation of Influenza-like Illness as a Predictor of Influenza Jonathan L. Temte, MD/PhD & Alexis Eastman, MS-2 University of Wisconsin School

Additional Material

Page 21: Community Validation of Influenza-like Illness as a Predictor of Influenza Jonathan L. Temte, MD/PhD & Alexis Eastman, MS-2 University of Wisconsin School

Basic Characteristics of Surveillance System

Mean age of patient = 26.6 years Range [ 0 to 103 years]

Sex Female = 55.6% Male = 44.4%

Time between illness onset and collection Mean = 3.86 days Median = 2 days

Rate of virus isolation = 44.6%

Page 22: Community Validation of Influenza-like Illness as a Predictor of Influenza Jonathan L. Temte, MD/PhD & Alexis Eastman, MS-2 University of Wisconsin School

Specimens Collected during

“Respiratory Virus” Season

0

50

100

150

200

250

300

350

0 4 8 12 16 20 24 28 32 36 40 44 48 52

Weeks after July 1st

Nu

mb

er

of

Sp

ecim

en

s

Page 23: Community Validation of Influenza-like Illness as a Predictor of Influenza Jonathan L. Temte, MD/PhD & Alexis Eastman, MS-2 University of Wisconsin School

Collection Day(Monday through Thursday

Preferred)

0

5

10

15

20

25

SUN MON TUE WED THU FRI SAT

% o

f S

pec

imen

s

Page 24: Community Validation of Influenza-like Illness as a Predictor of Influenza Jonathan L. Temte, MD/PhD & Alexis Eastman, MS-2 University of Wisconsin School

Most SpecimensCollected at Optimal Time

0102030405060708090

100

0 3 6 9 12 15 18 21 24 27 30

Days after Onset of Illness

Cu

mu

lati

ve P

erce

nta

ge

Page 25: Community Validation of Influenza-like Illness as a Predictor of Influenza Jonathan L. Temte, MD/PhD & Alexis Eastman, MS-2 University of Wisconsin School

Percent of Specimens with Positive Virus

Isolation

0

0.1

0.2

0.3

0.4

0.5

0.6

0 1 2 3 4 5 6 7

Days after Onset of Illness

% p

osit

ive